Skip to content

Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation

Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05717855
Enrollment
52
Registered
2023-02-08
Start date
2020-09-21
Completion date
2021-04-21
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

2D Ultrasound, Cavum Septum Pellucidum, Optic Chiasma, Septooptic Dysplasia, Willis Polygon

Brief summary

Evaluation of prenatal optic chiasm (OC) is important for the differential diagnosis of septo-optic dysplasia (SOD), which is a congenital optic disc anomaly, and the absence of the cavum septum pellucidum (CSP). Septo-optic dysplasia is associated with a wide range of neurological abnormalities, including hypoplasia of the visual pathways, CSP agenesis, and developmental delay.

Detailed description

Up to now, optic chiasm measurement were all done in the third trimester. in the present study, OC will be measure directly in a 2D ultrasound in coronal plane within the second trimester. In fetuses with SP agenesis, the morphology and width of the OC visual pathway may be a suitable tool to assess its development. It can also assist in the difficult task of providing prenatal counseling when faced with a diagnosis of CP agenesis. therefore In the present study, it was planned to show the optic chiasm in the screening of septooptic dysplasia by ultrasound between 16-20 weeks of gestation, and to measure the optic chiasma width and length, and to determine the mean values in the second trimester.

Interventions

DIAGNOSTIC_TESTDisplaying optic chiasm for screening septooptic dysplasia

Displaying and measuring the width and length of the optic chiasm for screening septooptic dysplasia with ultrasound between 16-20 weeks of gestation

Sponsors

Gaziosmanpasa Research and Education Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* aged greater than 18 years old * having singleton pregnancy

Exclusion criteria

* being under the age of 18 * having IVF pregnancy * having multiple pregnancy * comorbidity during pregnancy * smoking history * presence of familial genetic disease

Design outcomes

Primary

MeasureTime frame
Calculation of average width of OC according to gestational week in millimeter2 months
Calculation of average height of OC according to gestational week in millimeter2 months
Calculation of average area of OC according to gestational week millimeter square2 months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026